234
Participants
Start Date
September 30, 2010
Primary Completion Date
October 31, 2011
Study Completion Date
October 31, 2011
Linagliptin
Active drug 1 tablet PO QD
Placebo
1 Tablet PO QD
1218.75.059 Boehringer Ingelheim Investigational Site, Birmingham
1218.75.054 Boehringer Ingelheim Investigational Site, Huntsville
1218.75.035 Boehringer Ingelheim Investigational Site, Mobile
1218.75.101 Boehringer Ingelheim Investigational Site, Toney
1218.75.066 Boehringer Ingelheim Investigational Site, Little Rock
1218.75.008 Boehringer Ingelheim Investigational Site, Pell City
1218.75.071 Boehringer Ingelheim Investigational Site, Anaheim
1218.75.018 Boehringer Ingelheim Investigational Site, Chino
1218.75.081 Boehringer Ingelheim Investigational Site, Garden Grove
1218.75.109 Boehringer Ingelheim Investigational Site, Los Angeles
1218.75.040 Boehringer Ingelheim Investigational Site, Colorado Springs
1218.75.047 Boehringer Ingelheim Investigational Site, Denver
1218.75.106 Boehringer Ingelheim Investigational Site, Bartow
1218.75.098 Boehringer Ingelheim Investigational Site, Bradenton
1218.75.036 Boehringer Ingelheim Investigational Site, Chiefland
1218.75.105 Boehringer Ingelheim Investigational Site, Fort Lauderdale
1218.75.083 Boehringer Ingelheim Investigational Site, Fort Myers
1218.75.002 Boehringer Ingelheim Investigational Site, Hialeah
1218.75.080 Boehringer Ingelheim Investigational Site, Jacksonville
1218.75.065 Boehringer Ingelheim Investigational Site, Jupiter
1218.75.007 Boehringer Ingelheim Investigational Site, Miami
1218.75.029 Boehringer Ingelheim Investigational Site, Miami
1218.75.045 Boehringer Ingelheim Investigational Site, Miami
1218.75.084 Boehringer Ingelheim Investigational Site, Miami
1218.75.017 Boehringer Ingelheim Investigational Site, Ocala
1218.75.012 Boehringer Ingelheim Investigational Site, Pinellas Park
1218.75.074 Boehringer Ingelheim Investigational Site, Port Orange
1218.75.076 Boehringer Ingelheim Investigational Site, South Miami
1218.75.003 Boehringer Ingelheim Investigational Site, St. Petersburg
1218.75.039 Boehringer Ingelheim Investigational Site, St. Petersburg
1218.75.075 Boehringer Ingelheim Investigational Site, Tallahassee
1218.75.100 Boehringer Ingelheim Investigational Site, Tamarac
1218.75.015 Boehringer Ingelheim Investigational Site, Tampa
1218.75.103 Boehringer Ingelheim Investigational Site, West Palm Beach
1218.75.049 Boehringer Ingelheim Investigational Site, Atlanta
1218.75.067 Boehringer Ingelheim Investigational Site, Calhoun
1218.75.016 Boehringer Ingelheim Investigational Site, Dunwoody
1218.75.063 Boehringer Ingelheim Investigational Site, Lawrenceville
1218.75.056 Boehringer Ingelheim Investigational Site, Marietta
1218.75.026 Boehringer Ingelheim Investigational Site, Rosswell
1218.75.079 Boehringer Ingelheim Investigational Site, Sandy Springs
1218.75.034 Boehringer Ingelheim Investigational Site, Snellville
1218.75.001 Boehringer Ingelheim Investigational Site, Chicago
1218.75.055 Boehringer Ingelheim Investigational Site, Chicago
1218.75.069 Boehringer Ingelheim Investigational Site, Owensboro
1218.75.044 Boehringer Ingelheim Investigational Site, Baton Rouge
1218.75.108 Boehringer Ingelheim Investigational Site, Essex
1218.75.086 Boehringer Ingelheim Investigational Site, Brockton
1218.75.087 Boehringer Ingelheim Investigational Site, Watertown
1218.75.051 Boehringer Ingelheim Investigational Site, Detroit
1218.75.088 Boehringer Ingelheim Investigational Site, Flint
1218.75.099 Boehringer Ingelheim Investigational Site, Biloxi
1218.75.006 Boehringer Ingelheim Investigational Site, Atco
1218.75.004 Boehringer Ingelheim Investigational Site, Camden
1218.75.031 Boehringer Ingelheim Investigational Site, Brooklyn
1218.75.095 Boehringer Ingelheim Investigational Site, Brooklyn
1218.75.038 Boehringer Ingelheim Investigational Site, Asheboro
1218.75.009 Boehringer Ingelheim Investigational Site, Charlotte
1218.75.023 Boehringer Ingelheim Investigational Site, Charlotte
1218.75.060 Boehringer Ingelheim Investigational Site, Charlotte
1218.75.005 Boehringer Ingelheim Investigational Site, Greensboro
1218.75.107 Boehringer Ingelheim Investigational Site, High Point
1218.75.020 Boehringer Ingelheim Investigational Site, Jacksonville
1218.75.027 Boehringer Ingelheim Investigational Site, Winston-Salem
1218.75.096 Boehringer Ingelheim Investigational Site, Akron
1218.75.090 Boehringer Ingelheim Investigational Site, Columbus
1218.75.078 Boehringer Ingelheim Investigational Site, Dayton
1218.75.037 Boehringer Ingelheim Investigational Site, Philadelphia
1218.75.082 Boehringer Ingelheim Investigational Site, Philadelphia
1218.75.010 Boehringer Ingelheim Investigational Site, Uniontown
1218.75.028 Boehringer Ingelheim Investigational Site, Uniontown
1218.75.091 Boehringer Ingelheim Investigational Site, Anderson
1218.75.072 Boehringer Ingelheim Investigational Site, Columbia
1218.75.068 Boehringer Ingelheim Investigational Site, Greenwood
1218.75.097 Boehringer Ingelheim Investigational Site, Greer
1218.75.024 Boehringer Ingelheim Investigational Site, Brentwood
1218.75.025 Boehringer Ingelheim Investigational Site, Collierville
1218.75.011 Boehringer Ingelheim Investigational Site, Germantown
1218.75.042 Boehringer Ingelheim Investigational Site, Humboldt
1218.75.030 Boehringer Ingelheim Investigational Site, Memphis
1218.75.050 Boehringer Ingelheim Investigational Site, Memphis
1218.75.053 Boehringer Ingelheim Investigational Site, Dallas
1218.75.057 Boehringer Ingelheim Investigational Site, Houston
1218.75.064 Boehringer Ingelheim Investigational Site, Houston
1218.75.104 Boehringer Ingelheim Investigational Site, Houston
1218.75.043 Boehringer Ingelheim Investigational Site, Houton
1218.75.022 Boehringer Ingelheim Investigational Site, San Antonio
1218.75.058 Boehringer Ingelheim Investigational Site, Sugar Land
1218.75.033 Boehringer Ingelheim Investigational Site, Tomball
1218.75.102 Boehringer Ingelheim Investigational Site, Tomball
1218.75.094 Boehringer Ingelheim Investigational Site, Waco
1218.75.092 Boehringer Ingelheim Investigational Site, Whitney
1218.75.019 Boehringer Ingelheim Investigational Site, Virgnia Beach
Lead Sponsor
Eli Lilly and Company
INDUSTRY
Boehringer Ingelheim
INDUSTRY